Literature DB >> 24241959

Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Madeeha Aqil1, Zane Deliu, Kim M Elseth, Grace Shen, Jiaping Xue, James A Radosevich.   

Abstract

Previous work has shown enhanced survival capacity in high nitric oxide (HNO)-adapted tumor cells. In Part I of this series of manuscripts, we have shown that A549-HNO cells demonstrate an improved growth profile under UV and X-ray radiation treatment. These cells exhibit increased expression of proteins involved in DNA damage recognition and repair pathway, both the non-homologous end joining pathway and homologous recombination. These include Ku80, DNA-PK, XLF ligase and MRN complex proteins. Further, the A549-HNO cells show high levels of ATM, ATR, Chk1 and Chk2, and phospho-p53. Activation of these molecules may lead to cell cycle arrest and apoptosis due to DNA damage. This is observed in parent A549 cells in response to NO donor treatment; however, the A549-HNO cells proliferate and inhibit apoptosis. Cell cycle analysis showed slowed progression through S phase which will allow time for DNA repair. Thus, to better understand the increased growth rate in A549-HNO when compared to the parent cell line A549, we studied molecular mechanisms involved in cell cycle regulation in A549-HNO cells. During the initial time period of NO donor treatment, we observe high levels of cyclin/Cdk complexes involved in regulating various stages of the cell cycle. This would lead to bypass of G1-S and G2-M checkpoints. The HNO cells also show much higher expression of Cdc25A. Cdc25A activates Cdk molecules involved in different phases of the cell cycle. In addition, there is enhanced phosphorylation of the Rb protein in HNO cells. This leads to inactivation of Rb/E2F checkpoint regulating G1-S transition. This may lead to faster progression in S phase. Thus, all of these perturbations in HNO cells lead to accelerated cell cycle progression and a higher growth rate. We also assessed expression of cell cycle inhibitors in HNO cells. Interestingly, the HNO cells show a significant decline in p21CIP1 at initial time points, but with prolonged exposure, the levels were much higher than those of the parent cells. This suggests an initial bypass of cell cycle checkpoints as p21CIP1 can inhibit the activity of all cyclin/Cdk complexes. p21CIP1 is also known to inhibit p53-induced apoptosis. This could be important during later phases of the cell cycle to allow time for repair of damaged DNA and thus better survival of HNO cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24241959     DOI: 10.1007/s13277-013-1319-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

Review 2.  CDC25A: a rebel within the CDC25 phosphatases family?

Authors:  Anne Fernandez-Vidal; Anne Mazars; Stéphane Manenti
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

3.  NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling.

Authors:  Claus Storgaard Sørensen; Marina Melixetian; Ditte Kjaersgaard Klein; Kristian Helin
Journal:  Cell Cycle       Date:  2010-02-03       Impact factor: 4.534

4.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.

Authors:  A Lopez-Girona; B Furnari; O Mondesert; P Russell
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

Review 5.  Phosphorylation network dynamics in the control of cell cycle transitions.

Authors:  Daniel Fisher; Liliana Krasinska; Damien Coudreuse; Béla Novák
Journal:  J Cell Sci       Date:  2012-10-15       Impact factor: 5.285

Review 6.  DNA damage checkpoints in stem cells, ageing and cancer.

Authors:  Tobias Sperka; Jianwei Wang; K Lenhard Rudolph
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09       Impact factor: 94.444

Review 7.  Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis.

Authors:  V S Romanov; V A Pospelov; T V Pospelova
Journal:  Biochemistry (Mosc)       Date:  2012-06       Impact factor: 2.487

8.  Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.

Authors:  H De Vitto; B S Mendonça; K M Elseth; B J Vesper; E A Portari; C V M Gallo; W A Paradise; F D Rumjanek; J A Radosevich
Journal:  Tumour Biol       Date:  2012-12-14

9.  Regulation of lung cancer cell growth and invasiveness by beta-TRCP.

Authors:  Nonggao He; Chengxin Li; Xiaoli Zhang; Tao Sheng; Sumin Chi; Kai Chen; Qian Wang; Roger Vertrees; Roberto Logrono; Jingwu Xie
Journal:  Mol Carcinog       Date:  2005-01       Impact factor: 4.784

10.  Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.

Authors:  I Hoffmann; G Draetta; E Karsenti
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  5 in total

Review 1.  Genetics of Adrenocortical Development and Tumors.

Authors:  Maya Lodish
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

2.  Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.

Authors:  Birandra K Sinha
Journal:  J Cancer Sci Ther       Date:  2016-10-28

3.  A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Authors:  Madeeha Aqil; Kim M Elseth; Ashok Arjunakani; Philip Nebres; Courtney P Amegashie; Devang H Thanki; Premal B Desai; James A Radosevich
Journal:  Tumour Biol       Date:  2014-12-11

4.  DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide.

Authors:  Berna Demircan; Burcu Yucel; James A Radosevich
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways.

Authors:  Madeeha Aqil; Kim M Elseth; Benjamin J Vesper; Zane Deliu; Bulent Aydogan; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.